Literature DB >> 27025218

[Effect of the German Act on the reform of the market for medicinal products (AMNOG) on the quality of neurological and psychiatric treatment].

H Hamer1, A Meyer-Lindenberg2.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27025218     DOI： 10.1007/s00115-016-0102-4

Source DB:  PubMed          Journal:  Nervenarzt        ISSN： 0028-2804            Impact factor:   1.214


× No keyword cloud information.
  4 in total

Review 1.  Learning from the past and looking to the future: Emerging perspectives for improving the treatment of psychiatric disorders.

Authors:  Mark J Millan; Guy M Goodwin; Andreas Meyer-Lindenberg; Sven Ove Ögren
Journal:  Eur Neuropsychopharmacol       Date:  2015-02-07       Impact factor: 4.600

2.  60 years of advances in neuropsychopharmacology for improving brain health, renewed hope for progress.

Authors:  Mark J Millan; Guy M Goodwin; Andreas Meyer-Lindenberg; Sven Ove Ögren
Journal:  Eur Neuropsychopharmacol       Date:  2015-02-07       Impact factor: 4.600

3.  The economic cost of brain disorders in Europe.

Authors:  J Olesen; A Gustavsson; M Svensson; H-U Wittchen; B Jönsson
Journal:  Eur J Neurol       Date:  2012-01       Impact factor: 6.089

Review 4.  The size and burden of mental disorders and other disorders of the brain in Europe 2010.

Authors:  H U Wittchen; F Jacobi; J Rehm; A Gustavsson; M Svensson; B Jönsson; J Olesen; C Allgulander; J Alonso; C Faravelli; L Fratiglioni; P Jennum; R Lieb; A Maercker; J van Os; M Preisig; L Salvador-Carulla; R Simon; H-C Steinhausen
Journal:  Eur Neuropsychopharmacol       Date:  2011-09       Impact factor: 4.600
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.